Evidence map›Paper›PMID 31186531›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2019

DNA methylation-based classification of sinonasal undifferentiated carcinoma.

Snjezana Dogan, Varshini Vasudevaraja, Bin Xu, Jonathan Serrano, Ryan N Ptashkin, Hun Jae Jung, Sarah Chiang, Achim A Jungbluth, Marc A Cohen, Ian Ganly and 6 more

Open access · greenAbstract read
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed, 1 pooled it
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 1 synthesis or guideline pooled it, 133 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Epigenetic alterations in head and neck cancer: a brief update.Virchows Archiv : an international journal of pathology · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Clinical, genetic and immunohistochemical characterization of sinonasal tumors with neuroectodermal differentiation.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. NONO regulates mJournal of experimental & clinical cancer research : CR · 2025
    Article
  15. Analysis of ASCL1/NEUROD1/POU2F3/YAP1 Yields Novel Insights for the Diagnosis of Olfactory Neuroblastoma and Identifies Sinonasal Tuft Cell-Like Carcinoma.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Snjezana DoganDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. dogans@mskcc.org.
Varshini VasudevarajaDepartment of Pathology, NYU Langone Health and School of Medicine, New York, NY, USA.
Bin XuDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Jonathan SerranoDepartment of Pathology, NYU Langone Health and School of Medicine, New York, NY, USA.
Ryan N PtashkinDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Hun Jae JungDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Sarah ChiangDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Achim A JungbluthDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Marc A CohenDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ian GanlyDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Michael F BergerDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Amir Momeni BoroujeniDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ronald A GhosseinDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Marc LadanyiDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Deborah J ChuteDepartment of Pathology, Cleveland Clinic Foundation, Cleveland, OH, USA.
Matija SnuderlDepartment of Pathology, NYU Langone Health and School of Medicine, New York, NY, USA.
Memorial Sloan Kettering Cancer Center · USNYU Langone Health · USCleveland Clinic · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Sinonasal undifferentiated carcinoma (SNUC) is an aggressive malignancy harboring IDH2 R172 mutations in >80% cases. We explored the potential of genome-wide DNA methylation profiling to elucidate tumor biology and improve the diagnosis of sinonasal undifferentiated carcinoma and its histologic mimics. Forty-two cases, including sinonasal undifferentiated, large cell neuroendocrine, small cell neuroendocrine, and SMARCB1-deficient carcinomas and olfactory neuroblastoma, were profiled by Illumina Infinium Methylation EPIC array interrogating >850,000 CpG sites. The data were analyzed using a custom bioinformatics pipeline. IDH2 mutation status was determined by the targeted exome sequencing (MSK-IMPACT

Indexed as

DNA MethylationAdultAgedAged, 80 and overCarcinomaCarcinoma, NeuroendocrineCarcinoma, Small CellFemaleHumansImmunohistochemistryIsocitrate DehydrogenaseMaleMaxillary Sinus NeoplasmsMiddle AgedMutationSMARCB1 ProteinIsocitrate DehydrogenaseSMARCB1 ProteinSMARCB1 protein, human

Identifiers

PMID31186531
PMCPMC7391258
OpenAlexW2952311237

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.